NASDAQ : SSII
SS Innovations International, Inc. — Key statistics
Healthcare · Medical Devices · India
Last price 2.35 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 470.91M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 470.91M |
| Enterprise Value | 475.13M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 200.39M |
| Shares Outstanding | 200.39M |
| Shares Change (YoY) | +9.70% |
| Shares Change (QoQ) | +2.00% |
| Owned by Insiders (%) | 72.24% |
| Owned by Institutions (%) | 0.96% |
| Float | 40.67M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.07 |
| Forward PS | 7.05 |
| PB Ratio | 8.81 |
| P/TBV Ratio | 8.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 9.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.24 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.42 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -26.06% |
| Return on Assets (ROA) | -6.34% |
| Return on Invested Capital (ROIC) | -8.60% |
| Return on Capital Employed (ROCE) | -13.01% |
| Weighted Average Cost of Capital (WACC) | 8.16% |
| Revenue Per Employee | $108,499 |
| Profits Per Employee | -$25,742 |
| Employee Count | 483 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 1.49 |
Taxes
| Measure | Value |
|---|
| Income Tax | 4.27M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -70.88% |
| 50-Day Moving Average | 2.93 |
| 200-Day Moving Average | 3.86 |
| Relative Strength Index (RSI) | 37.48 |
| Average Volume (20 Days) | 55,649 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 69,591 |
| Short Previous Month | 67,764 |
| Short % of Shares Out | 0.03% |
| Short % of Float | 0.17% |
| Short Ratio (days to cover) | 1.00 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 52.40M |
| Gross Profit | 24.97M |
| Operating Income | -8.47M |
| Pretax Income | -8.16M |
| Net Income | -12.43M |
| EBITDA | -7.19M |
| EBIT | -8.47M |
| Loss Per Share | -$0.06 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 13.65M |
| Total Debt | 17.87M |
| Net Cash | -4.23M |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | 53.40M |
| Book Value Per Share | 0.27 |
| Working Capital | 39.56M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -15.53M |
| Capital Expenditures | -2.68M |
| Depreciation & Amortization | 1.28M |
| Net Borrowing | 7.65M |
| Free Cash Flow | -18.22M |
| FCF Per Share | -$0.09 |
Margins
| Measure | Value |
|---|
| Gross Margin | 47.65% |
| Operating Margin | -16.16% |
| Pretax Margin | -15.58% |
| Profit Margin | -23.73% |
| EBITDA Margin | -13.72% |
| EBIT Margin | -16.16% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -9.70% |
| Shareholder Yield | -9.70% |
| Earnings Yield | -2.70% |
| FCF Yield | -3.83% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 34.51% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 14.79 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |